Breaking News Instant updates and real-time market news.

REGN

Regeneron

$376.40

5.44 (1.47%)

, SNY

Sanofi

$44.17

-0.62 (-1.38%)

15:28
04/21/17
04/21
15:28
04/21/17
15:28

EMA's CHMP issues positive opinion on Kevzara in rheumatoid arthritis

The Committee for Medicinal Products for Human Use, or CHMP, of the EMA announced it has adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Kevzara, intended for the treatment of rheumatoid arthritis.

REGN

Regeneron

$376.40

5.44 (1.47%)

SNY

Sanofi

$44.17

-0.62 (-1.38%)

  • 24

    Apr

  • 03

    May

REGN Regeneron
$376.40

5.44 (1.47%)

03/29/17
SBSH
03/29/17
NO CHANGE
Target $420
SBSH
Buy
Citi sees upside to consensus expectations for Dupixent launch
Citi analyst Robyn Karnauskas believes Regeneron Pharmaceuticals is taking a smart approach to the Dupixent launch by going after the sickest moderate to severe atopic dermatitis patients. A lack of payer pushback, which is the biggest investor concern, could make the launch look better than the street expectations of $138M for 2017, Karnauskas tells investors in a research note. She keeps a Buy rating on Regeneron with a $420 price target.
03/29/17
FBCO
03/29/17
NO CHANGE
Target $485
FBCO
Outperform
Credit Suisse sees upside to Regeneron Dupixent if favorable payer environment
After FDA approved Regeneron (REGN) and Sanofi's (SNY) Dupixent, Credit Suisse analyst Alethia Young says that the pricing was higher than her expectations, but thinks that the peak opportunity is roughly around the same, remaining unchanged at $4.7B in 2025. Additionally, the analyst thinks that Regeneron/Sanofi upfront effort with payers may help early days of launch. She reiterates an Outperform rating and $485 price target on Regeneron's shares.
03/29/17
UBSW
03/29/17
NO CHANGE
Target $446
UBSW
Buy
Regeneron target raised to $446 on higher than expected Dupixent pricing at UBS
UBS analyst Carter Gould noted that on the call related to Dupixent's approval for atopic dermatitis Regeneron (REGN) and Sanofi (SNY) said that the drug's annual $37K gross price was expected to translate into a net price in the "low $30K range" annually, which is above his prior estimate near $24K. Along with raising his annual net pricing assumption, Gould increased his peak sales estimate for Dupixent in atopic dermatitis to $3.1B from $2.8B and raised his price target on Regeneron to $446 from $435 while keeping a Buy rating on the stock.
03/30/17
WEDB
03/30/17
NO CHANGE
Target $33
WEDB
Outperform
AnaptysBio price target raised to $33 from $28 at Wedbush
Wedbush analyst David Nierengarten raised his price target for AnaptysBio (ANAB) to $33 from $28 saying that Regeneron (REGN) and Sanofi's (SNY) Dupixent price suggests that higher pricing for the former's ANB020 could be achievable. The analyst reiterates an Outperform rating on AnaptysBio's shares.
SNY Sanofi
$44.17

-0.62 (-1.38%)

04/07/17
04/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lamb Weston (LW) downgraded to Hold from Buy at Stifel with analyst Christopher Growe citing the 44% up move in shares since he launched coverage in November 2016. 2. AstraZeneca (AZN), Novo Nordisk (NVO), Sanofi (SNY), Roche (RHHBY), and Grifols (GRFS) were downgraded to Reduce from Hold at HSBC. 3. AECOM (ACM) downgraded to Neutral from Outperform at Baird with analyst Andrew Wittmann saying the company filed an amendment to its credit agreement suggesting likely risk to 2017 earnings, as the filing implies the company would have breached its leverage covenant without an amendment. The analyst is also cautious given the relative obscurity of the filing. Wittmann lowered his price target to $40 from $45 on AECOM shares. 4. Arista Networks (ANET) downgraded to Neutral on valuation at Nomura with analyst Jeffrey Kvaal citing valuation. 5. Maximus (MMS) downgraded to Hold from Buy at Canaccord analyst Richard Close citing expectations of a slow near-term RFP and contract award environment given the recent Trump administration transition. click here.
04/07/17
RAJA
04/07/17
NO CHANGE
RAJA
Strong Buy
Flexion CMO hiring adds to Raymond James' skepticism of takeover speculation
Raymond James analyst Elliot Wilbur previously said he was skeptical of media-driven speculation that Sanofi (SNY) was preparing to bid for Flexion (FLXN), but he views the appointment of Yamo Deniz, another former Sanofi executive, as Flexion's chief medical officer as one more reason to doubt the rumor. Deniz "joins a growing roster of hires" from Sanofi and Wilbur does not believe these individuals, who "would have the best firsthand knowledge of exactly what the buzz is on Zilretta from the Sanofi perspective," would join Flexion simply to rejoin Sanofi again. While he thinks "some deflation" of the takeout premium in the stock could follow this hiring, Wilbur keeps a Strong Buy rating on Flexion shares.
04/11/17
JPMS
04/11/17
UPGRADE
JPMS
Neutral
Sanofi upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Richard Vosser upgraded Sanofi to Neutral saying he no longer sees downside to consensus estimates. The pressure on the diabetes business now seems largely reflected in estimates, Vosser tells investors in a research note. The analyst raised his price target for the shares to EUR 87 from EUR 71.
04/11/17
04/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Conviction Buy from Buy at Goldman with analyst Drew Borst saying that the success of "Beauty and the Beast" has increased his confidence in his forecast that FY18 EPS growth will accelerate given the company's promising film slate and its read-through to consumer products. He also sees accelerating profit growth at ESPN given normalizing NBA costs and predicts record results for the Theme Parks segment. Borst keeps a $138 price target on Disney shares. 2. McDonald's (MCD) upgraded to Buy from Neutral at Cleveland Research. 3. Yelp (YELP) upgraded to Overweight from Sector Weight at Pacific Crest with analyst Brad Erickson saying his checks with local ad customers indicate Yelp's core franchise is healthy and appears insulated from larger competitors like Google (GOOG, GOOGL) and Facebook (FB). 4. Toll Brothers (TOL) upgraded to Outperform from Sector Perform at RBC Capital with analyst Robert Wetenhall citing "solid demand,strong execution, proven management, a strong luxury housing business, and consistent earnings." 5. Sanofi (SNY) upgraded to Neutral from Underweight at JPMorgan with analyst Richard Vosser saying he no longer sees downside to consensus estimates. The pressure on the diabetes business now seems largely reflected in estimates, Vosser tells investors in a research note. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

HLX

Helix Energy

$5.69

-0.29 (-4.85%)

18:18
07/23/17
07/23
18:18
07/23/17
18:18
Earnings
Helix Energy reports Q2 EPS (4c), consensus (3c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

SFTBF

SoftBank

$82.90

-0.25 (-0.30%)

, S

Sprint

$8.53

0.15 (1.79%)

17:31
07/23/17
07/23
17:31
07/23/17
17:31
Periodicals
SoftBank Son considering Uber stake, NY Post says »

SoftBank's (SFTBF)…

SFTBF

SoftBank

$82.90

-0.25 (-0.30%)

S

Sprint

$8.53

0.15 (1.79%)

BABA

Alibaba

$151.89

-0.22 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 03

    Aug

  • 08

    Aug

BX

Blackstone

$34.42

0.14 (0.41%)

17:27
07/23/17
07/23
17:27
07/23/17
17:27
Periodicals
Blackstone in talks to acquire 40% of cyber firm NSO, Reuters reports »

Blackstone is said to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$972.92

4.77 (0.49%)

, GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

17:23
07/23/17
07/23
17:23
07/23/17
17:23
Periodicals
EU $2.7B fine to overshadow Alphabet results, Recode says »

When Alphabet reports its…

GOOG

Alphabet

$972.92

4.77 (0.49%)

GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

GOOG

Alphabet

$972.92

4.77 (0.49%)

, GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

17:18
07/23/17
07/23
17:18
07/23/17
17:18
Periodicals
Google having trouble rolling out news feed on Android devices, Recode says »

Google (GOOG; GOOGL)…

GOOG

Alphabet

$972.92

4.77 (0.49%)

GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

FB

Facebook

$164.43

-0.1 (-0.06%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

  • 01

    Aug

  • 13

    Sep

BMWYY

BMW

$31.52

-0.73 (-2.26%)

, DDAIF

Daimler AG

$72.94

-1.4991 (-2.01%)

17:12
07/23/17
07/23
17:12
07/23/17
17:12
Periodicals
BMW denies cartel allegations, NY Times reports »

Responding to claims it…

BMWYY

BMW

$31.52

-0.73 (-2.26%)

DDAIF

Daimler AG

$72.94

-1.4991 (-2.01%)

VLKAY

Volkswagen

$32.98

-0.725 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$19.38

0.07 (0.36%)

, WBMD

WebMD

$55.19

-0.06 (-0.11%)

17:07
07/23/17
07/23
17:07
07/23/17
17:07
Periodicals
KKR nearing deal to acquire WebMD, Reuters reports »

Private equity firm KKR…

KKR

KKR

$19.38

0.07 (0.36%)

WBMD

WebMD

$55.19

-0.06 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

YTRA

Yatra

$11.03

-0.32 (-2.82%)

17:02
07/23/17
07/23
17:02
07/23/17
17:02
Hot Stocks
Yatra to acquire Air Travel Bureau »

Yatra has announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEN

Kenon

16:58
07/23/17
07/23
16:58
07/23/17
16:58
Hot Stocks
Yoav Doppelt stepping down as Kenon CEO »

Kenon has announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEN

Kenon

16:54
07/23/17
07/23
16:54
07/23/17
16:54
Hot Stocks
Kenon considering sale of IC Power businesses in Latin America »

Kenon has announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UA

Under Armour

$18.84

-0.21 (-1.10%)

, UAA

Under Armour

16:50
07/23/17
07/23
16:50
07/23/17
16:50
Hot Stocks
Before the Move: Watch Under Armour after Spieth wins British open »

Jordan Spieth beat fellow…

UA

Under Armour

$18.84

-0.21 (-1.10%)

UAA

Under Armour

NKE

Nike

$59.95

0.85 (1.44%)

ADDYY

adidas

$103.40

-1.17 (-1.12%)

DKS

Dick's Sporting

$37.16

-0.07 (-0.19%)

ELY

Callaway Golf

$12.74

-0.01 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 22

    Aug

  • 23

    Aug

CTL

CenturyLink

$23.37

0.15 (0.65%)

12:35
07/22/17
07/22
12:35
07/22/17
12:35
Periodicals
CenturyLink CEO disagrees with Minnesota Attorney General claims, Reuters says »

CenturyLink CEO Glen Post…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

DB

Deutsche Bank

$18.22

-0.24 (-1.30%)

, JPM

JPMorgan

$90.89

-0.31 (-0.34%)

12:30
07/22/17
07/22
12:30
07/22/17
12:30
Periodicals
Deutsche Bank, JPMorgan to pay $148M to end yen Libor litigation, Reuters says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$18.22

-0.24 (-1.30%)

JPM

JPMorgan

$90.89

-0.31 (-0.34%)

C

Citi

$66.00

-0.36 (-0.54%)

HSBC

HSBC

$47.86

-0.25 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 27

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

VLKAY

Volkswagen

$32.98

-0.725 (-2.15%)

, BMWYY

BMW

$31.52

-0.73 (-2.26%)

12:20
07/22/17
07/22
12:20
07/22/17
12:20
Periodicals
EU regulators investigating German car cartel allegations, Reuters reports »

EU antitrust regulators…

VLKAY

Volkswagen

$32.98

-0.725 (-2.15%)

BMWYY

BMW

$31.52

-0.73 (-2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$32.98

-0.725 (-2.15%)

12:11
07/22/17
07/22
12:11
07/22/17
12:11
Periodicals
Seat chief sees CNG as an alternative to diesel, Reuters reports »

Seat, a wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$109.31

-0.53 (-0.48%)

12:03
07/22/17
07/22
12:03
07/22/17
12:03
Periodicals
Toyota to begin mass EV production in China as early as 2019, Reuters says »

Toyota Motor is likely to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$212.14

1.86 (0.88%)

, EADSY

Airbus

$20.89

-0.08 (-0.38%)

11:57
07/22/17
07/22
11:57
07/22/17
11:57
Periodicals
Boeing looking to rely on more factory automation, WSJ reports »

Boeing (BA) is cutting…

BA

Boeing

$212.14

1.86 (0.88%)

EADSY

Airbus

$20.89

-0.08 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

PUGOY

Peugeot

$21.51

-0.716 (-3.22%)

, GM

General Motors

$36.07

-0.34 (-0.93%)

11:50
07/22/17
07/22
11:50
07/22/17
11:50
Periodicals
Open defends employee leases inclusion in sales figures, Reuters reports »

Opel, which is being…

PUGOY

Peugeot

$21.51

-0.716 (-3.22%)

GM

General Motors

$36.07

-0.34 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

FB

Facebook

$164.43

-0.1 (-0.06%)

, AAPL

Apple

$150.27

-0.07 (-0.05%)

11:39
07/22/17
07/22
11:39
07/22/17
11:39
Periodicals
Facebook, Apple troubles in China no longer a surprise, NY Times says »

Facebook (FB), Apple…

FB

Facebook

$164.43

-0.1 (-0.06%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

MSFT

Microsoft

$73.79

-0.43 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

  • 05

    Sep

  • 13

    Sep

WFC

Wells Fargo

$54.17

-0.71 (-1.29%)

10:14
07/22/17
07/22
10:14
07/22/17
10:14
Periodicals
Wells Fargo investigating information sent to attorney, Bloomberg reports »

Wells Fargo said it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 15

    Jan

COKE

Coca-Cola Bottling

$240.86

-0.94 (-0.39%)

09:51
07/22/17
07/22
09:51
07/22/17
09:51
Hot Stocks
Coca-Cola Bottling announces 25c dividend for third quarter »

Coca-Cola Bottling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.61

0.01 (0.01%)

09:41
07/22/17
07/22
09:41
07/22/17
09:41
Periodicals
Procter & Gamble finds itself 'besieged again,' Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

PG

Procter & Gamble

$88.61

0.01 (0.01%)

09:40
07/22/17
07/22
09:40
07/22/17
09:40
Periodicals
Procter & Gamble finds itself 'besieged again,' Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

DF

Dean Foods

$15.35

-0.02 (-0.13%)

09:33
07/22/17
07/22
09:33
07/22/17
09:33
Periodicals
Cheddar prices could rise further, Barron's says »

Prices for block cheddar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

KR

Kroger

, FDX

FedEx

$212.51

0.63 (0.30%)

09:25
07/22/17
07/22
09:25
07/22/17
09:25
Periodicals
Issuing debt to fund pensions 'not cause for worry,' Barron's says »

Issuing debt to fund…

KR

Kroger

FDX

FedEx

$212.51

0.63 (0.30%)

DAL

Delta Air Lines

$52.26

-0.57 (-1.08%)

DD

DuPont

$84.54

-0.29 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.